Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12611000352909Phase 4Not yet recruiting
Phase 4, randomised, open-label trial of parecoxib in postoperative pain, sponsored by Dr. Elsa Taylor. Primary endpoints: Pain scores in Group 1 across parecoxib dose levels and Parecoxib blood levels. Planned start Aug 2011; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12611000352909.